Accurate Clinical Management - Houston

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Rheumatoid arthritis2 trials

Phase

• Phase 42 trials

Status

• Completed2 trials

Lead sponsor

• Eli Lilly and Company2 trials

Closed trials

• Completed

  A Study of Baricitinib in Participants With Rheumatoid Arthritis

  NCT04086745· Phase 4· Eli Lilly and Company· Source

• Completed

  A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

  NCT03915964· Phase 4· Eli Lilly and Company· Source